MiR-101 targets USP22 to inhibit the tumorigenesis of papillary thyroid carcinoma.Huadong Zhao, Guoqiang Bao, Haili Tang et al.|PubMed|2016Cited by 31
A protocol for a multidisciplinary early intervention during chemotherapy to improve dietary management behavior in breast cancer patients: a two-arm, single-center randomized controlled trialHan Tang, Lei Shang, Wei Zhang et al.|BMC Cancer|2024Cited by 11
Chinese expert consensus on transoral vestibular approach robotic thyroidectomy and parathyroidectomy (version 2024)Qingqing He, Haitao Zheng, Wen Tian et al.|Journal of Robotic Surgery|2024Cited by 5
Correction: Chinese expert consensus on transoral vestibular approach robotic thyroidectomy and parathyroidectomy (version 2024)Qingqing He, Haitao Zheng, Wen Tian et al.|Journal of Robotic Surgery|2025Cited by 1
Abstract PO1-27-01: Comparing the Efficacy and Safety of TQB2440 versus the Reference Pertuzumab for the Treatment of HER2-Positive Early or Locally Advanced Breast Cancer: A Multicenter, Randomized, Double-Blind, Parallel-Controlled Phase 3 TrialQingyuan Zhang, Qingshan Li, Zhangjun Song et al.|Cancer Research|2024Cited by 0